Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07638618 · ClinicalTrials.gov registry record · NA
Healthy Choices to Reduce Stigma and Improve Self-Management of Alcohol and HIV Among Young Adults
A NA study, sponsored by Florida State University.
- Not yet
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07638618: Clinical Trial NA study, sponsored by Florida State University.
NCT07638618 is a NA study that has not yet begun recruiting, run by Florida State University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07638618, a NA study, has not yet begun recruiting, sponsored by Florida State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The Spanish language Healthy Choices intervention pilot study (N=45) holds direct relevance to the United States and federal priorities related to improving HIV outcomes to reduce transmission using implementation science models. If Healthy Choices is found to have a clinical signal of impact, our team is committed to testing the intervention in the United States and training Spanish speaking HIV care navigators on the intervention, specifically in the southern United States where Spanish speaking populations are concentrated, namely in Alabama, Texas, New Mexico, Arizona, Nevada, and Florida.
Primary Outcome
Feasibility by the Feasibility of Intervention Measure (9 items)
Interventions
- BEHAVIORAL Healthy Choices
- OTHER Time Attention Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2027-10-01 |
| Est. Completion | 2029-02-28 |
| Phase | NA |
What is known before NCT07638618 opens enrollment
NCT07638618 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Healthy Choices is the first listed.
NCT07638618 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07638618 about?
NCT07638618 is a clinical study titled "Healthy Choices to Reduce Stigma and Improve Self-Management of Alcohol and HIV Among Young Adults". The Spanish language Healthy Choices intervention pilot study (N=45) holds direct relevance to the United States and federal priorities related to improving HIV outcomes to reduce transmission using implementation science models. If Healthy Choices is found to have a clinical signal of impact, our t...
What is the current status of trial NCT07638618?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2027-10-01. Estimated completion is 2029-02-28.
What interventions are being tested in trial NCT07638618?
The interventions under investigation include: Healthy Choices (BEHAVIORAL), Time Attention Control (OTHER).
Who is sponsoring clinical trial NCT07638618?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07638618's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI